2008-07
2008-06
2008-05
2008-04
2008-03
2008-02
2008-01
| Abiraterone - wikipedia, the free encyclopedia Abiraterone is currently a drug under investigation for use in prostate cancer. It blocks the formation of testosterone by inhibiting CYP17A1 (CYP450c17), an enzyme also known as ... Abiraterone - wikipedia, the free encyclopedia Fri, 25 Apr 2008 06:31:00 GMT, |
| Study of abiraterone acetate in patients with prostate cancer - full ... Study of Abiraterone Acetate in Patients With Prostate Cancer This study is ongoing, but not recruiting participants. Study of abiraterone acetate in patients with prostate cancer - full ... Fri, 18 Jul 2008 11:47:00 GMT, |
| Abiraterone acetate in castration-resistant prostate cancer previously ... Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy This study is currently recruiting participants. Verified by Cougar ... Abiraterone acetate in castration-resistant prostate cancer previously ... Sun, 20 Jul 2008 06:58:00 GMT, |
| Preliminary phase ii results of abiraterone acetate in patients with ... UroToday.com - Dr. Danila, spoke about abiraterone acetate (AA), an oral and irreversible inhibitor of CYP17 that decreases testosterone and DHT levels to undetectable. The study ... Preliminary phase ii results of abiraterone acetate in patients with ... Fri, 18 Jul 2008 15:57:00 GMT, |
| Cougar biotechnology announces initiation of phase iii trial of cb7630 ... CGRB) announced that it has started enrolling patients in its Phase III clinical trial (COU-AA-301) of the Company's lead drug candidate CB7630 (abiraterone ace Cougar biotechnology announces initiation of phase iii trial of cb7630 ... Wed, 16 Jul 2008 14:41:00 GMT, |
| Studio-5.financialcontent.com Cougar Biotechnology to Present Clinical Data on CB7630 (Abiraterone Acetate) at American Society of Clinical Oncology 2008 Annual Meeting Studio-5.financialcontent.com Thu, 17 Jul 2008 22:03:00 GMT, |
| Studio-5.financialcontent.com Cougar Biotechnology Presents Positive CB7630 (Abiraterone Acetate) Phase I and Phase II Data at ASCO 2008 Annual Meeting Studio-5.financialcontent.com Sun, 13 Jul 2008 18:05:00 GMT, |
| Cougar biotechnology announces initiation of phase iii trial of cb7630 ... Cougar Biotechnology Announces Initiation of Phase III Trial of CB7630 (Abiraterone Acetate) Cougar biotechnology announces initiation of phase iii trial of cb7630 ... Sun, 20 Jul 2008 21:31:00 GMT, |
| Cougar biotechnology presents positive cb7630 (abiraterone acetate ... LOS ANGELES--(BUSINESS WIRE)--Cougar Biotechnology, Inc. (NASDAQ: CGRB) today announced that results from ongoing Phase I and Phase II clinical trials of Cougar’s Cougar biotechnology presents positive cb7630 (abiraterone acetate ... Sun, 20 Jul 2008 09:50:00 GMT, |
| Cougar biotechnology to present clinical data on cb7630 (abiraterone ... Cougar Biotechnology to Present Clinical Data on CB7630 (Abiraterone Acetate) at American Society of Clinical Oncology 2008 Annual Meeting Cougar biotechnology to present clinical data on cb7630 (abiraterone ... Sat, 19 Jul 2008 03:17:00 GMT, |
